DIAGRAPH-M Tablet
Metformin Hcl 500 mg + Glimepride 2 mg (Extended Release)
Indication
*Non insulin dependent type 2 diabetic
Glimepiride:
The rate of reduction of Hba(1c) was fastest in patients receiving glimepiride.
Superior action on blodd glucose level.
Glimepride does not show adverse effect on cardiac functions.
Metformin:
Improves glucose tolerance in patients with type 2 diabetes (NIDDM), lowering both basal and postprandial plasma glucose.
Useful in reducing postprandial hyperglycaemia.
The insulin sensitizer, metformin, is mainly used in subjects with type 2 diabetes who are obese.